首页> 美国卫生研究院文献>other >Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: Demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI)
【2h】

Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: Demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI)

机译:基于脂质体的粘液穿透颗粒(MPP)用于粘膜治疗:防磁化学交换饱和转移(diaCEST)磁共振成像(MRI)的演示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mucus barriers lining mucosal epithelia reduce the effectiveness of nanocarrier-based mucosal drug delivery and imaging (“theranostics”). Here, we describe liposome-based mucus-penetrating particles (MPP) capable of loading hydrophilic agents, e.g., the diaCEST MRI contrast agent barbituric acid (BA). We observed that polyethylene glycol (PEG)-coated liposomes containing ≥7 mol% PEG diffused only ~10-fold slower in human cervicovaginal mucus (CVM) compared to their theoretical speeds in water. 7 mol%-PEG liposomes contained sufficient BA loading for diaCEST contrast, and provided improved vaginal distribution compared to 0 and 3 mol%-PEG liposomes. However, increasing PEG content to ~12 mol% compromised BA loading and vaginal distribution, suggesting that PEG content must be optimized to maintain drug loading and in vivo stability. Non-invasive diaCEST MRI illustrated uniform vaginal coverage and longer retention of BA-loaded 7 mol %-PEG liposomes compared to unencapsulated BA. Liposomal MPP with optimized PEG content hold promise for drug delivery and imaging at mucosal surfaces.
机译:粘膜上皮衬里的粘液屏障降低了基于纳米载体的粘膜药物递送和成像的有效性(“ theranostics”)。在这里,我们描述了能够负载亲水剂(例如diaCEST MRI造影剂巴比妥酸(BA))的基于脂质体的粘液穿透颗粒(MPP)。我们观察到,含有≥7 mol%PEG的聚乙二醇(PEG)包覆的脂质体在人宫颈阴道粘液(CVM)中的扩散速度仅比其在水中的理论速度慢约10倍。与0和3 mol%-PEG脂质体相比,7 mol%-PEG脂质体包含足够的BA负载以进行diaCEST对比,并提供改善的阴道分布。但是,将PEG含量增加至〜12 mol%会损害BA负荷和阴道分布,这表明必须优化PEG含量以维持药物负荷和体内稳定性。与未封装的BA相比,非侵入性diaCEST MRI显示了均匀的阴道覆盖度和BA负载的7 mol%-PEG脂质体的保留时间更长。具有优化PEG含量的脂质体MPP有望在粘膜表面进行药物递送和成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号